Roger Aston
Follow
Get notifications in MyBN when activity occurs.
Roger Aston
Non-Executive Chair / Immuron
Most Notable Role
Dr Roger Aston is one of the most experienced and commercially astute people in drug commercialisation in Australia. He has more than 20 years of experience in the pharmaceutical and healthcare industries in senior roles in the United Kingdom, Asia Pacific and Australia.
Dr Aston is both a scientist and seasoned biotechnology entrepreneur, with a successful track record in both fields. He has been the chief executive of PharmAust's wholly-owned subsidiary Pitney Pharmaceuticals, chief executive of Mayne Pharma Group, and executive chair & acting chief executive of PharmAust.
Dr Aston holds a Bachelor of Science (Honours) and a PhD from the University of Manchester.
Dr Aston is both a scientist and seasoned biotechnology entrepreneur, with a successful track record in both fields. He has been the chief executive of PharmAust's wholly-owned subsidiary Pitney Pharmaceuticals, chief executive of Mayne Pharma Group, and executive chair & acting chief executive of PharmAust.
Dr Aston holds a Bachelor of Science (Honours) and a PhD from the University of Manchester.
Lists and Charts
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 129th |  | ResApp Health | $3.8m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEWS: Tagged in Board Moves May 13, 2024 | 13 May 2024 |
| NEWS: Tagged in Board Moves August 28, 2023 | 28 Aug 2023 |
| NEW ROLE: Non-Executive Chair, PharmAust | 28 Aug 2023 |
| REMUNERATION UPDATE: Non-Executive Director, OncoSil Medical | 03 Nov 2020 |
| NEW ROLE: Non-Executive Chair, Immuron | 03 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, ResApp Health | 02 Nov 2020 |
| REMUNERATION UPDATE: Executive Chair, Acting CEO since 2018, PharmAust | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, ResApp Health | 24 Aug 2020 |
| REMUNERATION UPDATE: Executive Chair, Acting CEO since 2018, PharmAust | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Chair, ResApp Health | 30 Jun 2020 |
